Results 81 to 90 of about 118,017 (304)

Management Innovation for R&D Productivity Improvement [PDF]

open access: yes, 1998
publisher多摩 In order to increase a corporate competitiveness, it is essential to improve R&D productivity. An R&D productivity is defined from an R&D management innovation point of view.
Uenohara, Michiyuki   +2 more
core  

A bioinspired catalytic nanoplatform for ferroptosis‐immunotherapy synergy in metastatic cancer

open access: yesBMEMat, EarlyView.
The bioinspired nanoplatform MnMSN@MnP‐PEG co‐delivers manganese peroxidase and manganese ions to synergistically induce immunogenic ferroptosis and activate the cGAS‐STING pathway, eliciting potent antitumor immunity against primary and metastatic tumors.
Panpan Xue   +8 more
wiley   +1 more source

Sustainable Innovation and Impact on Triple Bottom Line Performance: Are Innovation Types Simple Mediators?

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT This study investigates the way sustainable innovation, conceptualized as a second‐order construct integrating sustainable orientation and innovation culture, impacts triple bottom line (TBL) performance. It also examines the mediating roles of product, process, organizational, and marketing innovations.
Nuno Fernandes Crespo   +1 more
wiley   +1 more source

An Autonomous and Distributed Mobility Management Scheme in Mobile Core Networks

open access: yesEAI Endorsed Transactions on Creative Technologies, 2016
The 5th generation mobile and wireless communication systems are expected to accommodate exploding traffic, increasing number of devices, and heterogeneous applications driven by proliferation of IoT and M2M technologies.
Hua Yang   +4 more
doaj   +1 more source

Intestinal morphology of NEC patients.

open access: yes, 2013
Ileal tissues from NEC patients were stained with hematoxylin and eosin and representative sections are shown. (A) Ileum of an A-NEC-XBP1u patient with severe morphological damage. (B) Ileum of an A-NEC-XBP1u patient with mild morphological damage. (C)
Marie-Chantal Struijs (475804)   +7 more
core   +1 more source

Making Value‐Chain Risks Visible: Extending ENCORE for Systemic Insights

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Businesses in all sectors, including downstream segments, depend on biodiversity and the ecosystem services it sustains, yet firms also exert pressures that accelerate biodiversity loss. The latter generates material risks for both companies and their financial stakeholders.
Hjalmar Funke   +3 more
wiley   +1 more source

Revisiting the Latin Vocabulary of Terminologia Histologica: II. Adjectives and Participles

open access: yesClinical Anatomy, EarlyView.
ABSTRACT Terminologia Histologica, the international standard nomenclature of human histology and cytology, contains 1093 Latin words that appear to be used as adjectives. Among these, we identified 56 (5%) with a variety of linguistic issues, including typographical or spelling errors, less favored spelling variants, and several unfortunate word ...
Paul E. Neumann   +7 more
wiley   +1 more source

Revisiting Vector-Input MACs

open access: yesIACR Transactions on Symmetric Cryptology
At Eurocrypt 2006, Rogaway and Shrimpton (RS06) presented the idea of vector-input MAC that accepts a vector consisting of variable-length bit strings.
Isamu Furuya, Kazuhiko Minematsu
doaj   +1 more source

Clinical and histological NEC incidence and NEC severity scores in Experiment 2.

open access: yes, 2014
(A) NEC incidence values are the sum of all clinical or histological NEC cases and expressed as percentage. Results were not significant. EA, n = 27; EG, n = 16. (B) Clinical NEC severity scores determined in the stomach (Stom), jejunum (Jej), ileum (Ile)
Barbara Stoll (631755)   +10 more
core   +1 more source

Model‐Informed Dose Optimization of Anakinra in Preterm Neonates Implications for Safe and Effective Dosing

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Anakinra, an interleukin‐1 receptor antagonist, shows promise for reducing inflammatory complications of premature birth. However, the pharmacokinetics (PK) of anakinra in neonates has not been characterized, limiting evidence‐based dosing. This study aimed to develop a population PK model for anakinra to guide dosing in preterm neonates.
Jia Li   +27 more
wiley   +1 more source

Home - About - Disclaimer - Privacy